Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.

Research output: Contribution to journalArticlepeer-review

94 Citations (Scopus)
Original languageEnglish
Pages (from-to)192-199
Number of pages8
JournalEuropean Journal of Pharmacology
Volume547(1-3)
Issue number1-3
DOIs
Publication statusPublished - 10 Oct 2006

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this